Matt Hartwig | IR |
Haywood Miller | Interim CEO |
Richard Lindahl | EVP, CFO & Treasurer |
Paul Williams | SVP, Products Business |
Joichi Sakai | Singular Research |
Nicholas Lorusso | TD Cowen |
Good day and thank you for standing by. Welcome to the Q2 2023 Emergent BioSolutions Inc. Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded.